Diversity of selective environmental substrates for human cytochrome P450 2A6:: alkoxyethers, nicotine, coumarin, N-nitrosodiethylamine, and N-nitrosobenzylmethylamine

被引:36
作者
Le Gal, A [1 ]
Dréano, Y [1 ]
Lucas, D [1 ]
Berthou, F [1 ]
机构
[1] Fac Med, Biochim Lab, F-29285 Brest, France
关键词
coumarin; CYP2A6; enzyme kinetics; nicotine; N-nitrosobenzylmethylamine; specificity; substrates;
D O I
10.1016/S0378-4274(03)00229-7
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 ;
摘要
Cytochrome P450 2A6 constitutes 5-10% of the total microsomal CYPs of human liver. Although CYP2A6 is the major coumarin 7-hydroxylase, other known substrates of CYP2A6 include many toxicants and precarcinogens. The chemical structure diversity of these substrates raises the question of their selectivity. Thus, kinetic parameters were determined for the hydroxylation of five substrates of diverse chemical structures known to be selective for cytochrome P450 2A6: methyl tert-butyl ether (MTBE), nicotine, coumarin, N-nitrosobenzylmethylamine (NBzMA), and N-nitrosodiethylamine (NDEA). Sources of enzymes were either human liver microsomes or heterologously expressed CYPs. Coumarin was shown to be the substrate with the highest affinity, followed by NDEA, nicotine, NBzMA, and MTBE. Variability of CYP2A6 catalytic activities in human liver was between 24-fold for MTBE to sevenfold for coumarin, while CYP2A6 content varied 68-fold in human liver microsomes. These five catalytic activities were highly significantly correlated between them and with hepatic CYP2A6 content. The most selective chemical inhibitor of these five substrates was shown to be 8-methoxypsoralen. Based upon chemical inhibition of the enzymatic activities of pure recombinant human CYPs, it cannot be totally excluded that P450s other than CYP2A6, especially CYP2E1, are involved, although to a lesser extent, in NDEA and NBzMA metabolism. In conclusion, the prototype probes for CYP2A6 phenotyping are coumarin and nicotine. (C) 2003 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:77 / 91
页数:15
相关论文
共 49 条
[1]   Cytochrome P450 metabolic dealkylation of nine N-nitrosodialkylamines by human liver microsomes [J].
Bellec, G ;
Dreano, Y ;
Lozach, P ;
Menez, JF ;
Berthou, F .
CARCINOGENESIS, 1996, 17 (09) :2029-2034
[2]   INVOLVEMENT OF CYTOCHROME-P450 3A ENZYME FAMILY IN THE MAJOR METABOLIC PATHWAYS OF TOREMIFENE IN HUMAN LIVER-MICROSOMES [J].
BERTHOU, F ;
DREANO, Y ;
BELLOC, C ;
KANGAS, L ;
GAUTIER, JC ;
BEAUNE, P .
BIOCHEMICAL PHARMACOLOGY, 1994, 47 (10) :1883-1895
[3]   COMPARISON OF CAFFEINE METABOLISM BY SLICES, MICROSOMES AND HEPATOCYTE CULTURES FROM ADULT HUMAN-LIVER [J].
BERTHOU, F ;
RATANASAVANH, D ;
RICHE, C ;
PICART, D ;
VOIRIN, T ;
GUILLOUZO, A .
XENOBIOTICA, 1989, 19 (04) :401-417
[4]  
Bourrie M, 1996, J PHARMACOL EXP THER, V277, P321
[5]  
BRADY JF, 1988, MOL PHARMACOL, V33, P148
[6]   HIGH VARIABILITY OF NITROSAMINE METABOLISM AMONG INDIVIDUALS - ROLE OF CYTOCHROMES P450 2A6 AND 2E1 IN THE DEALKYLATION OF N-NITROSODIMETHYLAMINE AND N-NITROSODIETHYLAMINE IN MICE AND HUMANS [J].
CAMUS, AM ;
GENESTE, O ;
HONKAKOSKI, P ;
BEREZIAT, JC ;
HENDERSON, CJ ;
WOLF, CR ;
BARTSCH, H ;
LANG, MA .
MOLECULAR CARCINOGENESIS, 1993, 7 (04) :268-275
[7]   EXPRESSION AND ALTERNATIVE SPLICING OF THE CYTOCHROME-P-450 CYP2A7 [J].
DING, SH ;
LAKE, BG ;
FRIEDBERG, T ;
WOLF, CR .
BIOCHEMICAL JOURNAL, 1995, 306 :161-166
[8]   Inhibition of coumarin 7-hydroxylase activity in human liver microsomes [J].
Draper, AJ ;
Madan, A ;
Parkinson, A .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1997, 341 (01) :47-61
[9]   THE CYP 2A GENE SUBFAMILY - SPECIES-DIFFERENCES, REGULATION, CATALYTIC ACTIVITIES AND ROLE IN CHEMICAL CARCINOGENESIS [J].
FERNANDEZSALGUERO, P ;
GONZALEZ, FJ .
PHARMACOGENETICS, 1995, 5 :S123-S128
[10]  
FERNANDEZSALGUERO P, 1995, AM J HUM GENET, V57, P651